Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Xenon Pharmaceuticals Inc.

NASDAQ: XENE · Life Sciences · 4 alerts · CIK 1582313

Share price
$39.26Close, Nov 16
Market cap
$3.86B
Shares outstanding
98.28MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Xenon Pharmaceuticals Inc. filings on SEC EDGAR ↗

9:20 AM ET Form 4
Insider Buying

Xenon Pharmaceuticals CFO Thomas Patrick Kelly Buys $560K of Stock

Thomas Patrick Kelly, CFO, bought 15,000 shares of Xenon Pharmaceuticals Inc. at $37.32 a share, worth $560K in total on Sep 30, 2026. Shares held after the trade: 15,000.

Value
$560K
Shares
15,000
Price
$37.32
Role
CFO
Trade date
Sep 30, 2026
9:19 AM ET Form 4
Insider Buying

Xenon Pharmaceuticals President & CEO Ian Mortimer Buys $1.12M of Stock

Ian Mortimer, President & CEO, bought 30,000 shares of Xenon Pharmaceuticals Inc. at $37.38 a share, worth $1.12M in total on Sep 30, 2026. Shares held after the trade: 49,923 (+150.6%).

Value
$1.12M
Shares
30,000
Price
$37.38
Role
President & CEO
Holding change
+150.6%
Trade date
Sep 30, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.